Chitotriosidase: A new inflammatory marker in diabetic complications

Pathobiology

Volumn 83, Issue 4, 2016, Pages 211-219

  Di Rosa, Michelino ^a   Malaguarnera, Lucia ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Chitotriosidase; Diabetes mellitus; Endothelial dysfunction; Inflammation; Macrophage activation

Indexed keywords

CHITOTRIOSIDASE; BETA N ACETYLHEXOSAMINIDASE; BIOLOGICAL MARKER;

ATHEROSCLEROSIS; BONE FRAGILITY; DEMENTIA; DIABETES MELLITUS; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; HUMAN; INFLAMMATION; MACROPHAGE ACTIVATION; NONALCOHOLIC FATTY LIVER; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; DIABETIC COMPLICATION; METABOLISM; PATHOLOGY;

BIOMARKERS; DIABETES COMPLICATIONS; DIABETES MELLITUS; HEXOSAMINIDASES; HUMANS;

EID: 84968867200     PISSN: 10152008     EISSN: 14230291     Source Type: Journal    
DOI: 10.1159/000443932     Document Type: Review

References (66)

1. Kitada M, Kume S, Takeda-Watanabe A, Kanasaki K, Koya D: Sirtuins and renal diseases: relationship with aging and diabetic nephropathy. Clin Sci (Lond) 2013; 124: 153-164.
2. Rabinovitch A, Suarez-Pinzon WL: Cytokines and their roles in pancreatic islet betacell destruction and insulin-dependent diabetes mellitus. Biochem Pharmacol 1998; 55: 1139-1149.
3. Bussink AP, Speijer D, Aerts JM, Boot RG: Evolution of mammalian chitinase(-like) members of family 18 glycosyl hydrolases. Genetics 2007; 177: 959-970.
4. Dickey BF: Exoskeletons and exhalation. N Engl J Med 2007; 357: 2082-2084.
5. Lee CG, Da Silva CA, Dela Cruz CS, Ahangari F, Ma B, Kang MJ, et al: Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury. Annu Rev Physiol 2013; 75: 479-501.
6. Boot RG, Renkema GH, Verhoek M, Strijland A, Bliek J, de Meulemeester TM, et al: The human chitotriosidase gene. Nature of inherited enzyme deficiency. J Biol Chem 1998; 273: 25680-25685.
7. Aguilera B, Ghauharali-van der Vlugt K, Helmond MT, Out JM, Donker-Koopman WE, Groener JE, et al: Transglycosidase activity of chitotriosidase: improved enzymatic assay for the human macrophage chitinase. J Biol Chem 2003; 278: 40911-40916.
8. Malaguarnera L: Chitotriosidase: the yin and yang. Cell Mol Life Sci 2006; 63: 3018-3029.
9. Hollak CE, van Weely S, van Oers MH, Aerts JM: Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease. J Clin Invest 1994; 93: 1288-1292.
10. Boot RG, Verhoek M, de Fost M, Hollak CE, Maas M, Bleijlevens B, et al: Marked elevation of the chemokine CCL18/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention. Blood 2004; 103: 33-39.
11. Di Rosa M, Malaguarnera G, De Gregorio C, D'Amico F, Mazzarino MC, Malaguarnera L: Modulation of chitotriosidase during macrophage differentiation. Cell Biochem Biophys 2013; 66: 239-247.
12. Artieda M, Cenarro A, Ganan A, Lukic A, Moreno E, Puzo J, et al: Serum chitotriosidase activity, a marker of activated macrophages, predicts new cardiovascular events independently of C-reactive protein. Cardiology 2007; 108: 297-306.
13. Di Rosa M, Zambito AM, Marsullo AR, Li Volti G, Malaguarnera L: Prolactin induces chitotriosidase expression in human macrophages through PTK, PI3-K, and MAPK pathways. J Cell Biochem 2009; 107: 881-889.
14. Di Rosa M, Musumeci M, Scuto A, Musumeci S, Malaguarnera L: Effect of interferongamma, interleukin-10, lipopolysaccharide and tumor necrosis factor-alpha on chitotriosidase synthesis in human macrophages. Clin Chem Lab Med 2005; 43: 499-502.
15. Sonmez A, Haymana C, Tapan S, Safer U, Celebi G, Ozturk O, Genc H, Dogru T, Tasci I, Erdem G, Taslipinar A, Aydogdu A, Yilmaz MI, Kurt I, Kutlu M: Chitotriosidase activity predicts endothelial dysfunction in type-2 diabetes mellitus. Endocrine 2010; 37: 455-459.
16. Zurawska-Plaksej E, Lugowska A, Hetmanczyk K, Knapik-Kordecka M, Piwowar A: Neutrophils as a source of chitinases and chitinase-like proteins in type 2 diabetes. PLoS One 2015; 10:e0141730.
17. Piwowar A, Knapik-Kordecka M, Warwas M: Concentration of leukocyte elastase in plasma and polymorphonuclear neutrophil extracts in type 2 diabetes. Clin Chem Lab Med 2000; 38: 1257-1261.
18. Grant MB, Guay C: Plasminogen activator production by human retinal endothelial cells of nondiabetic and diabetic origin. Invest Ophthalmol Vis Sci 1991; 32: 53-64.
19. Pearson JD: Vessel wall interactions regulating thrombosis. Br Med Bull 1994; 50: 776-788.
20. Schmidt AM, Hasu M, Popov D, Zhang JH, Chen J, Yan SD, et al: Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins. Proc Natl Acad Sci USA 1994; 91: 8807-8811.
21. Back M, Weber C, Lutgens E: Regulation of atherosclerotic plaque inflammation. J Intern Med 2015; 278: 462-482.
22. Cochain C, Zernecke A: Macrophages and immune cells in atherosclerosis: recent advances and novel concepts. Basic Res Cardiol 2015; 110: 34.
23. Buckley ML, Ramji DP: The influence of dysfunctional signaling and lipid homeostasis in mediating the inflammatory responses during atherosclerosis. Biochim Biophys Acta 2015; 1852: 1498-1510.
24. Legein B, Temmerman L, Biessen EA, Lutgens E: Inflammation and immune system interactions in atherosclerosis. Cell Mol Life Sci 2013; 70: 3847-3869.
25. Boot RG, van Achterberg TA, van Aken BE, Renkema GH, Jacobs MJ, Aerts JM, de Vries CJ: Strong induction of members of the chitinase family of proteins in atherosclerosis: chitotriosidase and human cartilage GP-39 expressed in lesion macrophages. Arterioscler Thromb Vasc Biol 1999; 19: 687-694.
26. Artieda M, Cenarro A, Ganan A, Jerico I, Gonzalvo C, Casado JM, et al: Serum chitotriosidase activity is increased in subjects with atherosclerosis disease. Arterioscler Thromb Vasc Biol 2003; 23: 1645-1652.
27. Malaguarnera L, Simpore J, Prodi DA, Angius A, Sassu A, Persico I, et al: A 24-bp duplication in exon 10 of human chitotriosidase gene from the sub-Saharan to the Mediterranean area: role of parasitic diseases and environmental conditions. Genes Immun 2003; 4: 570-574.
28. Malaguarnera L, Ohazuruike LN, Tsianaka C, Antic T, Di Rosa M, Malaguarnera M: Human chitotriosidase polymorphism is associated with human longevity in Mediterranean nonagenarians and centenarians. J Hum Genet 2010; 55: 8-12.
29. Canudas J, Cenarro A, Civeira F, Garci-Otin AL, Aristegui R, Diaz C, et al: Chitotriosidase genotype and serum activity in subjects with combined hyperlipidemia: effect of the lipidlowering agents, atorvastatin and bezafibrate. Metabolism 2001; 50: 447-450.
30. Seneviratne AN, Sivagurunathan B, Monaco C: Toll-like receptors and macrophage activation in atherosclerosis. Clin Chim Acta 2012; 413: 3-14.
31. Lee S, Huen S, Nishio H, Nishio S, Lee HK, Choi BS, Ruhrberg C, Cantley LG: Distinct macrophage phenotypes contribute to kidney injury and repair. J Am Soc Nephrol 2011; 22: 317-326.
32. Di Rosa M, De Gregorio C, Malaguarnera G, Tuttobene M, Biazzo F, Malaguarnera L: Evaluation of AMCase and CHIT-1 expression in monocyte macrophages lineage. Mol Cell Biochem 2013; 374: 73-80.
33. Di Rosa M, Malaguarnera G, De Gregorio C, Palumbo M, Nunnari G, Malaguarnera L: Immuno-modulatory effects of vitamin D 3 in human monocyte and macrophages. Cell Immunol 2012; 280: 36-43.
34. Pourcet B, Feig JE, Vengrenyuk Y, Hobbs AJ, Kepka-Lenhart D, Garabedian MJ, et al: LXRa regulates macrophage arginase 1 through PU.1 and interferon regulatory factor 8. Circ Res 2011; 109: 492-501.
35. Martinez FO, Helming L, Gordon S: Alternative activation of macrophages: an immunologic functional perspective. Ann Rev Immunol 2009; 27: 451-483.
36. Berry A, Balard P, Coste A, Olagnier D, Lagane C, Authier H, et al: IL-13 induces expression of CD36 in human monocytes through PPARgamma activation. Eur J Immunol 2007; 37: 1642-1652.
37. Kang K, Reilly SM, Karabacak V, Gangl MR, Fitzgerald K, Hatano B, et al: Adipocyte-derived Th2 cytokines and myeloid PPARdelta regulate macrophage polarization and insulin sensitivity. Cell Metab 2008; 7: 485-495.
38. Di Rosa M TD, Saccone S, Distefano G, Basile MS, Di Raimondo F, Malaguarnera L: Chitotriosidase expression during monocyte-derived dendritic cells differentiation and maturation. Inflammation 2015; 38: 2082-2091.
39. Wigren M, Nilsson J, Kolbus D: Lymphocytes in atherosclerosis. Clin Chim Acta 2012; 413: 1562-1568.
40. Jongstra-Bilen J, Haidari M, Zhu SN, Chen M, Guha D, Cybulsky MI: Low-grade chronic inflammation in regions of the normal mouse arterial intima predisposed to atherosclerosis. J Exp Med 2006; 203: 2073-2083.
41. Huang CC, Chung CM, Leu HB, Lin LY, Chiu CC, Hsu CY, et al: Diabetes mellitus and the risk of Alzheimer's disease: a nationwide population-based study. PloS One 2014; 9:e87095.
42. Steen E, Terry BM, Rivera EJ, Cannon JL, Neely TR, Tavares R, et al: Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease-is this type 3 diabetes? J Alzheimers Dis 2005; 7: 63-80.
43. Rosen C, Andersson CH, Andreasson U, Molinuevo JL, Bjerke M, Rami L, et al: Increased levels of chitotriosidase and YKL-40 in cerebrospinal fluid from patients with Alzheimer's disease. Dement Geriatr Cogn Dis Extra 2014; 4: 297-304.
44. Chong ZZ, Li F, Maiese K: Stress in the brain: novel cellular mechanisms of injury linked to Alzheimer's disease. Brain Res Brain Res Rev 2005; 49: 1-21.
45. Wang F, Guo X, Shen X, Kream RM, Mantione KJ, Stefano GB: Vascular dysfunction associated with type 2 diabetes and Alzheimer's disease: a potential etiological linkage. Med Sci Monit Basic Res 2014; 20: 118-129.
46. McGeer EG, McGeer PL: Innate immunity in Alzheimer's disease: a model for local inflammatory reactions. Mol Interv 2001; 1: 22-29.
47. Dirnagl U, Iadecola C, Moskowitz MA: Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 2006; 29: 391-397.
48. Di Rosa M, Dell'Ombra N, Zambito AM, Malaguarnera M, Nicoletti F, Malaguarnera L: Chitotriosidase and inflammatory mediator levels in Alzheimer's disease and cerebrovascular dementia. Eur J Neurosci 2006; 23: 2648-2656.
49. Sotgiu S, Barone R, Zanda B, Arru G, Fois ML, Arru A, Rosati G, Marchetti B, Musumeci S: Chitotriosidase in patients with acute ischemic stroke. Eur Neurol 2005; 54: 149-153.
50. Chitturi S, Abeygunasekera S, Farrell GC, Holmes-Walker J, Hui JM, Fung C, Karim R, Lin R, Samarasinghe D, Liddle C, Weltman M, George J: NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 2002; 35: 373-379.
51. de Rijke YB, van Berkel TJ: Rat liver Kupffer and endothelial cells express different binding proteins for modified low density lipoproteins. Kupffer cells express a 95-kDa membrane protein as a specific binding site for oxidized low density lipoproteins. J Biol Chem 1994; 269: 824-827.
52. Malaguarnera L, Di Rosa M, Zambito AM, dell'Ombra N, Di Marco R, Malaguarnera M: Potential role of chitotriosidase gene in nonalcoholic fatty liver disease evolution. Am J Gastroenterol 2006; 101: 2060-2069.
53. Bilzer M, Roggel F, Gerbes AL: Role of Kupffer cells in host defense and liver disease. Liver Int 2006; 26: 1175-1186.
54. Malaguarnera L, Di Rosa M, Zambito AM, dell'Ombra N, Nicoletti F, Malaguarnera M: Chitotriosidase gene expression in Kupffer cells from patients with non-alcoholic fatty liver disease. Gut 2006; 55: 1313-1320.
55. Varki A: Does DG42 synthesize hyaluronan or chitin?: A controversy about oligosaccharides in vertebrate development. Proc Natl Acad Sci USA 1996; 93: 4523-4525.
56. Friedman SL: Cellular sources of collagen and regulation of collagen production in liver. Semin Liver Dis 1990; 10: 20-29.
57. Bedossa P, Houglum K, Trautwein C, Holstege A, Chojkier M: Stimulation of collagen alpha 1(I) gene expression is associated with lipid peroxidation in hepatocellular injury: a link to tissue fibrosis? Hepatology 2013; 57: 1262-1271.
58. Lee CG, Herzog EL, Ahangari F, Zhou Y, Gulati M, Lee CM, et al: Chitinase 1 is a biomarker for and therapeutic target in sclerodermaassociated interstitial lung disease that augments TGF-beta1 signaling. J Immunol 2012; 189: 2635-2644.
59. Di Rosa M, Mangano K, De Gregorio C, Nicoletti F, Malaguarnera L: Association of chitotriosidase genotype with the development of non-alcoholic fatty liver disease. Hepatol Res 2013; 43: 267-275.
60. Carnevale V, Romagnoli E, D'Erasmo L, D'Erasmo E: Bone damage in type 2 diabetes mellitus. Nutr Metab Cardiovasc Dis 2014; 24: 1151-1157.
61. Tsukamoto I, Akagi M, Inoue S, Yamagishi K, Mori S, Asada S: Expressions of local reninangiotensin system components in chondrocytes. Eur J Histochem 2014; 58: 2387.
62. Johnstone B, Alini M, Cucchiarini M, Dodge GR, Eglin D, Guilak F, et al: Tissue engineering for articular cartilage repair-the state of the art. Eur Cell Mater 2013; 25: 248-267.
63. Musumeci G, Castrogiovanni P, Mazzone V, Szychlinska MA, Castorina S, Loreto C: Histochemistry as a unique approach for investigating normal and osteoarthritic cartilage. Eur J Histochem 2014; 58: 2371.
64. Gierisch JM, Myers ER, Schmit KM, McCrory DC, Coeytaux RR, Crowley MJ, et al: Prioritization of patient-centered comparative effectiveness research for osteoarthritis. Ann Intern Med 2014; 160: 836-841.
65. Rahman MM, Kopec JA, Anis AH, Cibere J, Goldsmith CH: Risk of cardiovascular disease in patients with osteoarthritis: a prospective longitudinal study. Arthritis Care Res (Hoboken) 2013; 65: 1951-1958.
66. Di Rosa M, Tibullo D, Vecchio M, Nunnari G, Saccone S, Di Raimondo F, Malaguarnera L: Determination of chitinases family during osteoclastogenesis. Bone 2014; 61: 55-63.